Home Newsfeeds Deutsche Bank Maintains Hold on Trane Technologies, Raises Price Target to $155

Deutsche Bank Maintains Hold on Trane Technologies, Raises Price Target to $155

Deutsche Bank analyst Nicole Deblase maintains Trane Technologies (NYSE:TT) with a Hold and raises the price target from $151 to $155.

byBenzinga Newsdesk

October 13, 2022

1 minute read

Deutsche Bank analyst Nicole Deblase maintains Trane Technologies (NYSE:TT) with a Hold and raises the price target from $151 to $155.

Model N, Ducommun, Perpetua Resources And Other Big Stocks Moving Higher On Monday

By Avi Kapoor

April 8, 10:17 AM

U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 0.1% on Monday.

AIRC

Analyst Ratings

Truist Securities Maintains Buy Rating for Take-Two Interactive: Here’s What You Need To Know

By Benzinga Insights

May 8, 1:00 PM

Truist Securities has decided to maintain its Buy rating of Take-Two Interactive (NASDAQ:TTWO) and raise its price target…

TTWO

HP Decides To Let Go Of 4K – 6K Employees After 11% Revenue Decline In Q4; Likely To Save $1.4B In Costs By FY25

By Anusuya Lahiri

November 23, 6:27 AM

HP Inc (NYSE:HPQ) announced an FY23 Future Ready Transformation plan, driving significant structural cost savings through digital transformation, portfolio optimization,…

HPQ

News

Viatris To Divest OTC, Women’s Healthcare, And API Businesses In Strategic Move, For Up To $6.94B Of Total Gross Proceeds

By Benzinga Newsdesk

October 2, 3:07 AM

Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously Communicated

VTRS

Deutsche Bank Maintains Hold on Trane Technologies, Raises Price Target to $155

Related Posts

Model N, Ducommun, Perpetua Resources And Other Big Stocks Moving Higher On Monday

Truist Securities Maintains Buy Rating for Take-Two Interactive: Here’s What You Need To Know

HP Decides To Let Go Of 4K – 6K Employees After 11% Revenue Decline In Q4; Likely To Save $1.4B In Costs By FY25

Viatris To Divest OTC, Women’s Healthcare, And API Businesses In Strategic Move, For Up To $6.94B Of Total Gross Proceeds